Medical specialists from France tagged as investigators in clinical trials studying Lymphoma
Total 275 results
-
Charles Herbaux, PhDSeen in:
- Montpellier, CHU de Montpellier
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
Charline MOULINSeen in:
- Vandœuvre-lès-Nancy, CHU Brabois
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Christian Dualé, MD, PhDSeen in:
- Clermont-Ferrand, Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand
Trials:- NCT04935684 (Principal Investigator)
-
Claire CALMETTESSeen in:
- Périgueux, CH Périgueux
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Claude-Eric Bulabois, MDSeen in:
- Grenoble, Service hématologie CHU Grenoble
Trials:- NCT04935684 (Principal Investigator)
-
Clémence SantanaSeen in:
- Lyon, Centre Léon Bérard
- Valence, CH de Valence
Trials:- NCT04797780 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions: -
Corinne HaiounSeen in:
- Créteil, Hôpital Henri Mondor
- Val De Marne, Créteil Cedex, Hôpital Henri Mondor
Trials:- NCT03779113 (Principal Investigator)
- NCT02300402 (Principal Investigator)
- NCT03786926 (Principal Investigator)
Conditions: -
Cristina CASTILLA LLORENTESeen in:
- Villejuif, Institut De Cancerologie Gustave Roussy
Trials:- NCT04531046 (Principal Investigator)
Conditions: -
Cyril AbdeddaimSeen in:
- Lille, Centre Oscar Lambret
- Lille, Oscar Lambret Center
- Nord, Lille, Site 3602 - Centre Oscar Lambret
Trials:- NCT03088059 (Principal Investigator)
- NCT05128825 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Carcinoma, Squamous Cell of Head and Neck;
- High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
-
Damien Roos-WeilSeen in:
- Cedex 13, Paris, Groupe Hospitalier Pitie-Salpetriere
- Cedex 13, Paris, Hôpital de la Pitié Salpétrière
- Paris, Hôpital Pitié Salpêtrière
Trials:- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT05246345 (Principal Investigator)
-
David Beauvais, MDSeen in:
- Lille, Service des Maladies du sang Hôpital HURIEZ, CHRU de Lille
Trials:- NCT04935684 (Principal Investigator)
-
David SIBON, DrSeen in:
- Paris, Hopital Necker
Trials:- NCT04802590 (Principal Investigator)
Conditions: -
Deborah Desmier, MDSeen in:
- Poitiers, Service d'hématologie greffe Hôpital St Louis
Trials:- NCT04935684 (Principal Investigator)
-
Elsa LESTANG, MDSeen in:
- Saint-Nazaire, CH Saint Nazaire
- Saint-Nazaire, Centre Hospitalier de St Nazaire
Trials:- NCT05298293 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions: -
Emmanuel BACHYSeen in:
- Lyon, Hospices Civils de Lyon
- Other, Pierre Benite Cedex, Centre Hospitalier Lyon Sud
- Pierre Benite, CHU Lyon-Sud
- Pierre Bénite, Emmanuel Bachy
Trials:- NCT05444712 (Principal Investigator)
- NCT04569032 (Principal Investigator)
- NCT06088654 (Principal Investigator)
- NCT04842877 (Principal Investigator)
-
Emmanuel Gyan, MDSeen in:
- Cedex 01, Tours, CHU de TOURS - Hôpital Bretonneau
- Tours, CHU Tours
- Tours, CHU de Tours
- Tours, Tours University Hospital
Trials:- NCT05178849 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04446962 (Principal Investigator)
- NCT02649790 (Principal Investigator)
- NCT05790733 (Principal Investigator)
Conditions:- Bone Marrow Biopsy;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS;
- Chemotherapy Effect;
- Aplasia
-
Emmanuelle FerrantSeen in:
- Cedex, Pierre Benite, Centre Hospitalier Lyon Sud
- Cedex, Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Emmanuelle NICOLAS-VIRELIZIER, DrSeen in:
- LYON Cedex 08, Centre Léon Bérard
Trials:- NCT04802590 (Principal Investigator)
Conditions: -
Emmanuelle TAVERNIER, MDSeen in:
- Saint-Étienne, CHU Saint-Etienne
- Saint-Étienne, Hématologie clinique Institut de Cancérologie de la Loire
Trials:- NCT03481868 (Principal Investigator)
- NCT04935684 (Principal Investigator)
-
Emmanuelle TchernonogSeen in:
- Herault, Montpellier Cedex 5, Hopital Saint Eloi
- Montpellier, CHU de Montpellier
Trials:- NCT04965493 (Principal Investigator)
- NCT05246345 (Principal Investigator)
-
Eric DUROT, DrSeen in:
- Reims, CHU de Reims
Trials:- NCT04802590 (Principal Investigator)
Conditions: -
Etienne Daguindau, MDSeen in:
- Besançon, Hématologie clinique CHU Besançon
Trials:- NCT04935684 (Principal Investigator)
-
Fabien Le Bras, MDSeen in:
- Créteil, Hôpital Henri Mondor
Trials:- NCT04703686 (Principal Investigator)
-
Fabrice Jardin, MDSeen in:
- Haute-Normandie, Rouen, Centre Henri Becquerel
- Rouen, Centre Henri Becquerel
Trials:- NCT04224493 (Principal Investigator)
- NCT04446962 (Principal Investigator)
-
Florence CymbalistaSeen in:
- Cedex, Bobigny, Hospital AVICENNE
Trials:- NCT04666038 (Principal Investigator)
Conditions:
Clinical Trials on Lymphoma
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
BioNova Pharmaceuticals (Shanghai) LTD.TerminatedFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Royal Marsden NHS Foundation TrustUnknownMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United Kingdom
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
BeiGeneCompletedCutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditionsChina, Taiwan, Germany, France, Canada, Italy
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Lymphoma, Large Cell | Diffuse, Mantle Cell Lymphoma, Lymphoma | Large B-Cell, DiffuseJapan, Korea, Republic of